Effect of Continuous Care Model in Patients with Hyperthyroidism in ira

Phase 4

• Conditions: Drug side effects and quality of life in patients with hyperthyroidism within a period of at least one month to a maximum of six months of taking antithyroid drugs; Continuous Care Model, drug side effects, quality of; life, hyperthyroidism

• Registration Number: TCTR20210408001
• Lead Sponsor: Faculty of Nursing and Midwifery(fnm), Tehran, Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-08
• Study Completion: 2021-05-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

1.Confirmation of the diagnosis of hyperthyroidism
2.History of taking antithyroid drugs for at least one month and up to six months
3.Patients in the age range of 18 to 60 years
4.Do not have acute Covid disease
5.No acute infectious disease affecting the tests
6.Have a minimum literacy
7.Willingness to participate in the study
8.Ability to make phone calls and use the WhatsApp application

Exclusion Criteria

1.The client is under a similar study at the same time
2.Viral and microbial diseases affecting the person
3.Recent radiotherapy or immunotherapy
4.Dissatisfaction with the continuation of participation in the study
5.Not participating in two sessions
6.History of taking drugs that affect thyroid tests
7.Known for perceptual and psychological disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
quality of life at 3 months after start of the intervention Ware and Sherbourne Health Survey Questionnaire SF - 36

Secondary Outcome Measures

Name	Time	Method
drug side effects at 3 months after start of the intervention Adverse drug reaction questionnaire